Reusable laryngoscope vs disposable: which one should you choose?

What is a reusable laryngoscope and how does it differ from disposable?

The answer to the reusable vs disposable debate depends heavily on your clinical volume, infection-control infrastructure, and long-term budget — and there is no single right answer for every department.

A reusable laryngoscope is an intubation device comprising a sterilisable handle and interchangeable blades designed to withstand multiple reprocessing cycles and be used across numerous patients. In contrast, a disposable laryngoscope — sometimes called a single-use laryngoscope — is manufactured from polycarbonate or similar polymers intended for one procedure only, then discarded. Both categories encompass direct laryngoscope designs (traditional Macintosh and Miller configurations) as well as video laryngoscope platforms equipped with CMOS camera chips.

Globally, the laryngoscope market reached approximately £503 million in 2026, with reusable platforms retaining around 59% of market share according to recent Mordor Intelligence data. That majority position reflects decades of clinical familiarity — but it is increasingly being challenged by advances in single-use manufacturing and tightening NHS infection-control standards.

Key structural differences between the two types

The most obvious difference lies in material and construction. A reusable laryngoscope handle is typically manufactured from chrome-plated brass or stainless steel, engineered to endure autoclave cycles, chemical disinfectants, and the mechanical stresses of repeated handling. Blades — whether Macintosh curved or Miller straight — are constructed from surgical-grade stainless steel and rated for a defined number of reprocessing cycles, commonly 50 to 200, depending on the manufacturer's validation data.

Disposable equivalents replicate the same geometry in injection-moulded plastic. They eliminate the reprocessing burden entirely, but introduce per-unit cost at every procedure, plus associated clinical waste. Think of it like a razor: the reusable handle demands upfront investment and maintenance, whereas the disposable blade trades ongoing cost for zero turnaround time.

Which clinical settings typically use each type?

High-volume NHS operating theatres with established sterile services departments (SSDs) tend to favour reusable laryngoscopy equipment, where the per-use cost amortises efficiently. Prehospital and emergency medicine settings, by contrast, increasingly adopt disposable or single-use video laryngoscopes, where rapid deployment and zero cross-contamination risk outweigh cost considerations. Intensive care units often occupy the middle ground, making the reusable-vs-disposable question particularly live in that context.

Sterilisation and reprocessing: what UK guidelines actually require

Reprocessing is the single most important compliance requirement for any department using a reusable laryngoscope — and it is also the area most frequently handled inconsistently in clinical practice.

UK reprocessing requirements are governed primarily by HTM 01-01 (Health Technical Memorandum 01-01), the definitive NHS guidance on the decontamination of medical devices. For reusable laryngoscopes, the standard pathway involves three sequential stages: cleaning, disinfection, and sterilisation, each with defined parameters.

The reprocessing pathway step by step

1. Point-of-use decontamination: Immediately after use, gross soiling is removed at the point of care. The laryngoscope blade is detached from the handle and both components are placed into a designated transport container.
2. Manual or automated cleaning: Components are cleaned in a washer-disinfector (WD) meeting EN ISO 15883 standards at a minimum temperature of 80°C for 10 minutes (A0 value ≥ 600). Manual cleaning with enzymatic detergent is acceptable only where automated options are unavailable, and carries higher variability risk.
3. Inspection and function testing: Blade light source integrity, hinge function, and surface condition are checked. Blades showing pitting, discolouration, or damaged insulation are withdrawn from service.
4. Sterilisation: Where the device is labelled as autoclavable, porous-load steam sterilisation at 134°C for 3 minutes (one cycle) or 121°C for 15 minutes meets HTM 01-01 requirements. Not all reusable laryngoscope handles are rated for autoclave — manufacturer instructions for use (IFU) must be followed precisely.
5. Packaging and storage: Sterilised components are sealed in validated pouches and stored in a clean, dry environment. Shelf life depends on packaging type and storage conditions per BS EN ISO 11607.

Why reprocessing failures happen — and how to prevent them

Practical testing in NHS SSD environments reveals that failures cluster around two points: inadequate manual pre-cleaning of the blade's light-pipe channel, and use of incompatible chemical disinfectants that degrade the blade's chrome coating over time. Departments that skip the inspection step — often under theatre turnaround pressure — are the most likely to deploy a functionally compromised blade. A dim or flickering light source during laryngoscopy is not merely inconvenient; in a difficult airway scenario, it is a patient safety event.

"Laryngoscope blades should be decontaminated between patients in accordance with the manufacturer's instructions and local infection-control policy. Evidence suggests conventional blades may carry residual protein contamination if not subjected to validated washer-disinfector cycles." — NHS Infection Prevention and Control guidance, updated 2025

Cost comparison: total cost of ownership for NHS settings

The widespread assumption that reusable automatically means cheaper is one of the most persistent misconceptions in anaesthetic equipment procurement — and the numbers tell a more nuanced story.

A single reusable laryngoscope handle typically costs between £45 and £120 (stainless steel, LED-compatible), while a standard reusable Macintosh blade retails at £15–£35. Set against a disposable equivalent at £4–£12 per unit, the upfront case for reusable seems clear. But total cost of ownership demands a fuller calculation.

The break-even calculation

At a reprocessing cost of £5 per cycle and a blade purchase price of £25, a reusable blade breaks even against a £7 disposable equivalent at approximately six uses. For a busy anaesthetic department conducting 1,000 intubations per year with a fleet of 20 blades, the reusable pathway can represent a saving of £6,000–£10,000 annually on blade cost alone — before accounting for SSD infrastructure overhead. Of course, low-volume or emergency settings may never reach that break-even point, making disposable economically rational.

Hidden costs that procurement teams often miss

Battery and bulb failure in older halogen-based reusable laryngoscopy systems is an underappreciated cost driver. Switching to LED laryngoscope handles — now the standard across most NHS trusts — significantly reduces this liability. Fibreoptic laryngoscope handles eliminate the bulb-in-blade design entirely, though they require more careful handling to protect the fibre bundle from kinking. When calculating true cost, procurement teams should also account for the labour cost of managing a blade inventory, tracking reprocessing records, and withdrawing worn blades from service.

UK regulatory compliance: UKCA, MHRA and ISO 7376 explained

For any laryngoscopy equipment placed on the UK market after 2023, UKCA marking is the primary conformity framework — but the transitional picture remains complex in 2026.

UKCA marking and the CE transition

Following Brexit, the UK Conformity Assessed (UKCA) mark replaced CE marking for medical devices sold in Great Britain. The MHRA extended recognition of CE-marked devices under certain conditions through 2025, but as of 2026, all newly registered laryngoscopes — reusable and disposable — sold in Great Britain must carry UKCA marking unless covered by a valid transitional arrangement. Northern Ireland continues to accept CE marking under the Windsor Framework. NHS procurement officers should verify current MHRA registration status for any laryngoscope system before contract award, as this affects both legal compliance and warranty validity.

ISO 7376 and what it means for blade compatibility

ISO 7376 defines the dimensional and performance requirements for laryngoscope handles and blades, including the standard fitting geometry that allows interchangeability between compliant handles and blades from different manufacturers. This compatibility matters practically: a trust that standardises on one handle brand should confirm ISO 7376 conformance before purchasing blades from a secondary supplier. Non-conforming combinations can result in loose blade-to-handle connections — a safety risk during laryngoscopy. All devices supplied to NHS trusts should carry documented evidence of ISO 7376 testing as part of their technical file.

Blade selection guide: Macintosh, Miller and beyond

Selecting the right blade type and size is as important as the reusable-vs-disposable decision itself. A poorly matched blade increases intubation difficulty regardless of how well the device is maintained.

Blade type and size reference table

LED vs fibreoptic vs halogen: which illumination system should you choose?

Halogen bulb-in-blade systems are now considered legacy technology in most UK trusts. LED laryngoscope handles — where the light source is in the handle rather than the blade — offer superior brightness (typically 40,000–60,000 lux at the blade tip), longer service life, and eliminate the per-blade bulb replacement cost. Fibreoptic laryngoscope handles transmit light via a fibre bundle integrated into the blade, providing excellent colour rendering and no bulb to fail — but they demand careful handling to prevent fibre breakage. For departments standardising reusable direct laryngoscopy equipment in 2026, LED is the practical default, with fibre as a premium option.

Clinical performance and real-world NHS evidence

How do reusable and disposable laryngoscopes actually perform when the pressure is on? The evidence is more balanced than either camp's advocates typically acknowledge.

Intubation success rates and glottic view quality

Multiple controlled studies and NHS audit data indicate that first-attempt intubation success rates are comparable between well-maintained reusable direct laryngoscopes and their single-use equivalents when both are new or newly sterilised. Why do some clinicians report a preference for disposable? In several NHS trust audits, reusable blades showing subtle surface wear — micro-pitting on the flange or a slightly dulled reflective surface — produced marginally inferior glottic views compared to a pristine disposable equivalent. This reinforces the importance of rigorous blade inspection protocols, not an inherent inferiority of the reusable format.

Video laryngoscope platforms — whether reusable or disposable — consistently demonstrate improved Cormack-Lehane grade visualisation over direct laryngoscopy, particularly in grades III and IV airways. The Difficult Airway Society (DAS) 2025 updated guidelines reinforce video laryngoscopy as a first-line tool in anticipated difficult intubation scenarios, a position that has accelerated NHS investment in video laryngoscopy equipment across both reusable and single-use configurations.

Durability, failure rates and NHS feedback

Based on NHS clinical feedback collated across anaesthetic departments in 2024–2025, the most commonly reported failure mode for reusable laryngoscopy equipment is light source failure at the point of use — occurring in an estimated 1–3% of cases where pre-use checks were either skipped or inadequate. Blade mechanical failure (hinge fracture, detachment) is rare with ISO 7376-compliant equipment but is more likely when non-compatible blade-handle pairings are used. Disposable laryngoscopes, by contrast, show near-zero equipment failure rates but are associated with occasional reports of inferior blade rigidity in cheaper polymer formulations — particularly relevant in difficult-airway cases requiring sustained laryngoscope pressure.

How to choose: a clinical decision framework

So how do you actually decide? The honest answer is that neither format is universally superior — the right choice depends on a structured evaluation of your department's specific context.

Decision criteria by setting type

Consider four core variables when building your decision framework: procedure volume, SSD access, infection-control policy, and budget horizon. A high-volume elective operating theatre with an on-site SSD running validated washer-disinfector cycles is the natural environment for a reusable laryngoscope programme. The per-use economics are compelling, the reprocessing infrastructure already exists, and the environmental impact of disposable waste at scale is considerable — an increasingly important consideration for NHS sustainability targets under the Greener NHS agenda.

Emergency departments, prehospital teams, and smaller district general hospitals without 24-hour SSD access present a different calculation. Here, the operational convenience and infection-control certainty of disposable laryngoscopes often justifies their higher per-unit cost. There is no turnaround delay, no reprocessing validation burden, and no risk of a blade being deployed without adequate sterilisation.

When to consider a hybrid approach

Many NHS trusts are now adopting hybrid strategies — maintaining a core fleet of reusable laryngoscopy equipment for planned theatre lists while stocking disposable video laryngoscopes for emergency airway management. This balances cost efficiency in the elective setting with operational speed and safety in unplanned scenarios. It also provides redundancy: if a reusable blade fails inspection or the SSD cycle is delayed, a single-use option is immediately available. When evaluating video laryngoscope platforms specifically, examine whether the system offers a reusable handle with disposable blade channel inserts — a design that captures some of the cost benefits of reuse while maintaining a single-use patient-contact surface.

Environmental and sustainability considerations

The environmental footprint of single-use laryngoscopy equipment is non-trivial. A department conducting 2,000 intubations annually generates significant clinical waste from disposable blades, packaging, and handles. Reusable laryngoscope systems reduce this substantially over their service life, aligning with NHS net zero commitments. That said, the water, energy, and chemical inputs of repeated sterilisation carry their own environmental cost — a full lifecycle analysis, rather than a simple headline comparison, is the appropriate basis for sustainability claims.

Frequently asked questions

Conclusion

The reusable laryngoscope remains the cost-efficient backbone of laryngoscopy equipment in high-volume NHS operating theatres — provided that reprocessing infrastructure, HTM 01-01 compliance, and blade inspection protocols are genuinely robust. Disposable options offer unmatched operational simplicity and infection-control certainty, making them the rational default in emergency, prehospital, and low-volume settings. For most NHS trusts in 2026, the most defensible strategy is a hybrid model: a validated reusable fleet for elective endotracheal intubation, paired with single-use video laryngoscopy capability for unplanned and difficult-airway events. Whatever your setting, the decision should be driven by evidence, total cost of ownership, and compliance — not habit or assumption.